{
    "Trade/Device Name(s)": [
        "On-Call\u2122 Multi-Drug Home Test Cup for Marijuana, Cocaine, Amphetamine, Methamphetamine, Ecstasy, Opiates, and Phencyclidine"
    ],
    "Submitter Information": "ACON Laboratories, Inc.",
    "510(k) Number": "K050878",
    "Predicate Device Reference 510(k) Number(s)": [
        "K031759"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LDJ",
        "DIO",
        "DKZ",
        "LAF",
        "DJG",
        "LCM"
    ],
    "Summary Letter Date": "June 8, 2005",
    "Summary Letter Received Date": "April 6, 2005",
    "Submission Date": "April 4, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.3870",
        "21 CFR 862.3250",
        "21 CFR 862.3100",
        "21 CFR 862.3610",
        "21 CFR 862.3650"
    ],
    "Regulation Name(s)": [
        "Marijuana, Cocaine, Amphetamine, Methamphetamine, Ecstasy, Opiates, and Phencyclidine test system",
        "Cannabinoid test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Marijuana",
        "Cocaine",
        "Amphetamine",
        "Methamphetamine",
        "Ecstasy",
        "Opiates",
        "Phencyclidine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunoassay",
        "Immunochromatographic assay",
        "Competitive binding"
    ],
    "Methodologies": [
        "Antigen-antibody immunochemistry",
        "Immunochromatographic testing"
    ],
    "Submission Type(s)": [
        "Cup",
        "Screening test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for On-Call Multi-Drug Home Test Cup for qualitative urine screening of seven drugs of abuse using lateral flow immunoassay technology",
    "Indications for Use Summary": "Rapid over-the-counter urine screening for Marijuana, Cocaine, Amphetamine, Methamphetamine, Ecstasy, Opiates, and Phencyclidine, providing preliminary results that require confirmatory GC/MS testing for positives",
    "fda_folder": "Toxicology"
}